The Spring Meeting of the German Society for Haematology and Medical Oncology (DGHO) will focus on the use, evaluation, and pricing of advanced therapy medicinal products (ATMPs) in haematology and oncology in Germany.
The conference will address the challenges in the approval of ATMPs, their health technology assessment, and reimbursement by statutory payers under the AMNOG scheme.
Berlin
Ask for a Free trial and get access to the latest stories
Our coverage includes:
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
REQUEST
an initial 10 day temporary access of APM Market Access.
